Add like
Add dislike
Add to saved papers

Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts.

BACKGROUND AND OBJECTIVES: Prevalence of genital human papillomavirus (HPV) infection in the general population is not known. No one test alone can detect all HPV infections.

GOAL OF THIS STUDY: To determine the prevalence of and risk factors for genital human papillomavirus (HPV) infections in healthy males. Voluntary Finnish Army conscripts were examined using peniscopy, cytology (PAP smear) and polymerase chain reaction (PCR) in brush cytology samples.

STUDY DESIGN: A total of 1,471 (99.6%) males completed the questionnaire soliciting their sexual habits, and 432 of them enrolled in the clinical study.

RESULTS: The study group differed from the nonattenders in that they reported more often genitourinary symptoms (P < 0.001), had more casual sexual partners (P = 0.002), and previous STDs (P < 0.001). Classical genital warts were present in 24/432 (5.6%) and papular lesions in 8/432 (1.9%) males. Acetowhite lesions were disclosed in 151/432 (35.0%) cases, of which 61 (14.1%) had peniscopically typical flat HPV lesions. Koilocytes were found in 13/201 (6.5%) PAP smears. HPV DNA was disclosed by PCR in 16.5% (47/285) of the adequate cell smears, and in 7.1% of the males with no peniscopic abnormalities. When considering the men with HPV-positive PCR findings and/or typical peniscopic pattern as HPV-infected (26.2%), many casual partners, previous STDs and no use of condom were significant risk factors for genital HPV infections in the logistic regression analysis.

CONCLUSIONS: The reliable assessment of the prevalence of genital HPV infections in healthy males is not only skewed by the selection of the study group by symptoms and promiscuity, but also by the lack of a universally acceptable screening method. The data confirm sexual promiscuity as the most important risk factor for genital HPV infections.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app